Vanguard Asset Management’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
Other funds holding ORIC
Vanguard Asset Management's ORIC Position: Q3 2026 in Review
Vanguard Asset Management increased its Oric Pharmaceuticals (ORIC) stake by 46% in Q3 2026, buying an estimated $144K and bringing the position to 36,758 shares worth $495K. The position accounts for ﹤0.01% of the portfolio, ranked #2186.
Vanguard Asset Management first reported a position in ORIC in Q1 2026 and has held it in 3 quarters since. 201 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.
- Vanguard Asset Management held 36,758 shares of Oric Pharmaceuticals worth $495K as of Q3 2026.
- Vanguard Asset Management bought 11,569 Oric Pharmaceuticals shares in Q3 2026, an estimated $144K.
- Oric Pharmaceuticals made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #2186 holding.
- Vanguard Asset Management first reported a position in Oric Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- 201 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.
Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.